J Versijpt, J C Debruyne, K J Van Laere, F De Vos, J Keppens, K Strijckmans, E Achten, G Slegers, R A Dierckx, J Korf, and J L De Reuck

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
Mult Scler 2005 11: 127-134. [Abstract] [PDF] [References]  

Christian Enzinger, Siegrid Strasser-Fuchs, Stefan Ropele, Peter Kapeller, Reinhold Kleinert, and Franz Fazekas

Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging
Mult Scler 2005 11: 135-139. [Abstract] [PDF] [References]  

Robert J Fox, Elizabeth Fisher, Jean Tkach, Jar-Chi Lee, Jeffrey A Cohen, and Richard A Rudick

Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications
Mult Scler 2005 11: 140-145. [Abstract] [PDF] [References]  

K Morgen, A LT Crawford, R D Stone, R Martin, N D Richert, J A Frank, and H F McFarland

Contrast-enhanced MRI lesions during treatment with interferonß-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis
Mult Scler 2005 11: 146-148. [Abstract] [PDF] [References]  

Jonathan E Walker, Shri N Giri, and Solomon B Margolin

A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis
Mult Scler 2005 11: 149-158. [Abstract] [PDF] [References]  

V Yadav, G Marracci, J Lovera, W Woodward, K Bogardus, W Marquardt, L Shinto, C Morris, and D Bourdette

Lipoic acid in multiple sclerosis: a pilot study
Mult Scler 2005 11: 159-165. [Abstract] [PDF] [References]  

U Baumhackl, L Kappos, E W Radue, P Freitag, A Guseo, M Daumer, and J Mertin

A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis
Mult Scler 2005 11: 166-168. [Abstract] [PDF] [References]  

M Pulicken, C N Bash, K Costello, A Said, C Cuffari, J L Wilterdink, J M Rogg, P Mills, and P A Calabresi

Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis
Mult Scler 2005 11: 169-174. [Abstract] [PDF] [References]  

Scott B Patten, Gordon Francis, Luanne M Metz, Maria Lopez-Bresnahan, Peter Chang, and Francois Curtin

The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis
Mult Scler 2005 11: 175-181. [Abstract] [PDF] [References]  

David C Mohr, Darcy Cox, and Natalia Merluzzi

Self-Injection Anxiety Training: a treatment for patients unable to self-inject injectable medications
Mult Scler 2005 11: 182-185. [Abstract] [PDF] [References]  

John J Randolph and Peter A Arnett

Depression and fatigue in relapsing-remitting MS: the role of symptomatic variability
Mult Scler 2005 11: 186-190. [Abstract] [PDF] [References]  

T Olivares, A Nieto, M P Sánchez, T Wollmann, M A Hernández, and J Barroso

Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis
Mult Scler 2005 11: 191-197. [Abstract] [PDF] [References]  

N Téllez, J Río, M Tintoré, C Nos, I Galán, and X Montalban

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
Mult Scler 2005 11: 198-202. [Abstract] [PDF] [References]  

Yael Goverover, Nancy Chiaravalloti, and John DeLuca

The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis
Mult Scler 2005 11: 203-212. [Abstract] [PDF] [References]  

K Rasova, P Brandejsky, E Havrdova, M Zalisova, and P Rexova

Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
Mult Scler 2005 11: 213-221. [Abstract] [PDF] [References]  

David C Mohr, Heather Burke, Victoria Beckner, and Natalia Merluzzi

A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis
Mult Scler 2005 11: 222-226. [Abstract] [PDF] [References]  

Bernard MJ Uitdehaag, Ludwig Kappos, Lars Bauer, Mark S Freedman, David Miller, Rupert Sandbrink, and Chris H Polman

Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization
Mult Scler 2005 11: 227-231. [Abstract] [PDF] [References]  

M B Patwardhan, D B Matchar, G P Samsa, D C McCrory, R G Williams, and T T Li

Cost of multiple sclerosis by level of disability: a review of literature
Mult Scler 2005 11: 232-239. [Abstract] [PDF] [References]  

Lesley J White and Rudolph H Dressendorfer

Factors limiting maximal oxygen uptake in exertional monoparesis
Mult Scler 2005 11: 240-241. [Abstract] [PDF] [References]  

Maurizia Maurelli, Roberto Bergamaschi, Elisa Candeloro, Alessandra Todeschini, and Giuseppe Micieli

Cerebral venous thrombosis and demyelinating diseases: report of a case in a clinically isolated syndrome suggestive of multiple sclerosis onset and review of the literature
Mult Scler 2005 11: 242-244. [Abstract] [PDF] [References]  

S Nolden, C Casper, A Kuhn, and H F Petereit

Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate
Mult Scler 2005 11: 245-248. [Abstract] [PDF] [References]  

J Garson, A Créange, A Dolei, P Ferrante, E Jouvin-Marche, P N Marche, F Rieger, K Ruprecht, M Saresella, S Sotgiu, R Tedder, and H Perron

Letter to the editor
Mult Scler 2005 11: 249-250. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.